HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jagan Rao Rana A. Sayeed Stefan Fischer Shaf Keshavjee Gail E. Darling Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, J. Articles by Darling, G. E. Search for Related Content PubMed PubMed Citation Articles by Rao, J. Articles by Darling, G. E. Related Collections Lung - cancer

Ann Thorac Surg 2007;84:934-939
© 2007 The Society of Thoracic Surgeons

---

Original Articles: General Thoracic

Prognostic Factors in Resected Satellite–Nodule T4 Non-Small Cell Lung Cancer

Division of Thoracic Surgery, Toronto General and Princess Margaret Hospitals, University Health Network, University of Toronto, Toronto, Ontario, Canada

Accepted for publication April 23, 2007.

^_* Address correspondence to Dr Darling, Division of Thoracic Surgery, Toronto General Hospital, 9N955, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada (Email: gail.darling{at}uhn.on.ca).

Presented at the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.

Background: The 1997 non-small cell lung cancer staging revisions assigned a T4 descriptor to satellite nodules in the primary tumor lobe. We reviewed our experience of satellite–nodule T4 non-small cell lung cancer following these revisions and evaluated prognostic factors for this group.

Methods: All patients who underwent resection of non-small cell lung cancer between April 1997 and June 2005 with satellite nodule(s) confirmed at pathologic examination were identified from our institutional Lung Tumor Registry. Case notes and pathology reports were reviewed and data collected on possible prognostic factors. Survival was modeled using the Kaplan–Meier method, and survival differences between groups were analyzed using the log-rank test.

Results: From 1,276 non-small cell lung cancer patients who underwent resection, 137 were staged pT4, and 35 were T4-satellite nodules. Median follow-up was 25 months (range, 1 to 102 months). Median main tumor size was 3.0 cm (range, 1 to 9.8 cm). Adenocarcinoma or bronchioloalveolar carcinoma was the predominant histologic diagnosis (n = 28; 80%). One-, 3- and 5-year survival was 86%, 69%, and 57%, respectively; median survival was 68 months. During the same period, 137 patients undergoing resection for all T4 lesions had a 1-, 3-, and 5-year survival of 68%, 53%, and 18%, respectively. Adenocarcinoma or bronchioloalveolar carcinoma histologic diagnosis (adenocarcinoma or bronchioloalveolar carcinoma versus squamous, 75% versus 67% 3-year survival; p = 0.0026), female gender (66% versus 49% for males, 5-year survival; p = 0.041), and absence of vascular invasion (no invasion versus vascular invasion, 74% versus 20% 5-year survival; p = 0.0101) were significant predictors of better survival.

Conclusions: Survival for resected T4 non-small cell lung cancer with satellite nodule(s) in the primary lobe is better than for other T4 lesions, and the T4 descriptor may unduly upstage these cases. The current T4 descriptor represents a heterogeneous population.

This article has been cited by other articles:

				P. E. Van Schil, J. M. Hendriks, and P. Lauwers Editorial comment: Staging of ipsilateral pulmonary nodules: back to the future Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 485 - 486. [Full Text] [PDF]